Literature DB >> 14142155

CLINICAL USES OF SEROMUCOID ESTIMATION.

J W KEYSER.   

Abstract

Keywords:  ARTHRITIS, RHEUMATOID; ASCITES; BLOOD PROTEINS; CEREBROSPINAL FLUID PROTEINS; DIAGNOSIS, DIFFERENTIAL; JAUNDICE; MASTECTOMY; MUCOPROTEINS; MYOCARDIAL INFARCT; NEOPLASM DIAGNOSIS; PNEUMONIA; RHEUMATIC FEVER; TUBERCULOSIS, PULMONARY

Mesh：

Substances：

Year:  1964        PMID： 14142155      PMCID： PMC2482739          DOI： 10.1136/pgmj.40.462.184

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  22 in total

1.  [Electrophoretic and immunological characteristics of globulins from ascitic fluids of neoplastic origin].

Authors:  G BISERTE; R HAVEZ; F GUERRIN; J LATURAZE; A HAYEM
Journal:  Clin Chim Acta       Date:  1961-11       Impact factor: 3.786

2.  [Mucoproteins of the serum. Practical importance of their determination].

Authors:  A VARAY; M MASSON
Journal:  Presse Med       Date:  1960-07-09       Impact factor: 1.228

3.  Mucoproteins of cerebrospinal fluid and blood in neurologic disorders.

Authors:  A ZLOTNICK; E WEISENBERG; I CHOWERS
Journal:  J Lab Clin Med       Date:  1959-08

4.  Mucoprotein content of cerebro-spinal fluid.

Authors:  A SILVERSTEIN; E M GREENSPAN
Journal:  Confin Neurol       Date:  1959

5.  Determination of the carbohydrates in the glycoproteins and mucoproteins of cerebrospinal fluid.

Authors:  E ROBOZ; R R APOSTOL; A M LUFT; W C HESS
Journal:  J Lab Clin Med       Date:  1957-05

6.  Studies of various tests for malignant neoplastic diseases. VIII. The determination of plasma or serum mucoprotein.

Authors:  M C RHEES; L D ELLERBROOK; S W LIPPINCOTT
Journal:  Am J Clin Pathol       Date:  1954-07       Impact factor: 2.493

7.  Serum mucoprotein level in differentiation of hepatogenic from obstructive jaundice.

Authors:  E M GREENSPAN; D A DREILING
Journal:  AMA Arch Intern Med       Date:  1953-04

8.  A comparative study of the serum glycoproteins in patients with parenchymatous hepatic disease or metastatic neoplasia.

Authors:  E M GREENSPAN; I LEHMAN; M M GRAFF; E B SCHOENBACH
Journal:  Cancer       Date:  1951-09       Impact factor: 6.860

9.  The serum polysaccharide level in malignancy and in other pathological conditions.

Authors:  M R SHETLAR; J V FOSTER
Journal:  Cancer Res       Date:  1949-09       Impact factor: 12.701

10.  Mucolytic enzyme systems. XI. Hyaluronidase inhibitor and serum mucoproteins in patients with lipoid nephrosis and acute glomerulonephritis.

Authors:  V C KELLEY; R A GOOD; D GLICK; M J OCHS
Journal:  J Clin Invest       Date:  1950-11       Impact factor: 14.808
View more
  2 in total

1.  Effects of infection on selected clinical and biochemical parameters in dogs.

Authors:  G Williams; P M Newberne
Journal:  Br J Exp Pathol       Date:  1970-06

2.  Interactions between glycosaminoglycans and proteins, with particular reference to a new technique for isolating serum glycoproteins.

Authors:  A J Anderson
Journal:  Biochem J       Date:  1967-03       Impact factor: 3.857
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.